Combination therapy with tirofiban and enoxaparin in acute coronary syndromes
- 1 December 1999
- journal article
- clinical trial
- Published by Elsevier in International Journal of Cardiology
- Vol. 71 (3) , 273-281
- https://doi.org/10.1016/s0167-5273(99)00171-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1998
- A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable AnginaNew England Journal of Medicine, 1998
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1998
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Effects of Platelet Glycoprotein IIb/IIIa Blockade With Tirofiban on Adverse Cardiac Events in Patients With Unstable Angina or Acute Myocardial Infarction Undergoing Coronary AngioplastyCirculation, 1997
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1997
- Low-molecular-weight heparin during instability in coronary artery diseaseThe Lancet, 1996
- Determination of MK-383, a non-peptide fibrinogen receptor antagonist, in human plasma and urine by radioimmunoassayJournal of Pharmaceutical and Biomedical Analysis, 1994
- Hemorrhagic Events during Therapy with Recombinant Tissue-Type Plasminogen Activator, Heparin, and Aspirin for Acute Myocardial InfarctionAnnals of Internal Medicine, 1991
- Effect of Heparin and Heparin Fractions on Platelet AggregationJournal of Clinical Investigation, 1980